Colorectal câncer, intestinal microbiota and antineoplastic therapy: Scoping review protocol
DOI:
https://doi.org/10.33448/rsd-v13i3.45330Keywords:
Colorectal neoplasms; Gastrointestinal microbiome; Antineoplastic agents.Abstract
Objective: To map protective factors related to the intestinal microbiota of adult colorectal cancer patients undergoing intravenous chemotherapy. Methodology: Scoping review protocol carried out from January to June 2023, according to the methodology of the Joanna Briggs Institute Evidence Synthesis, in accordance with the PRISMA-ScR checklist, following the steps proposed by the Joanna Briggs Institute: identifying the research question, the relevant studies, selecting the studies and mapping the data. The mnemonic PCC (population, concept and context) determined the research question: What are the protective factors for the intestinal microbiota of adult colorectal cancer patients undergoing intravenous chemotherapy? The acronym PCC was used for data collection, which took place from January to June 2023. The following sources of information were included: Lilacs/Virtual Health Library, Medline/PubMed, Embase and Scopus, Web of Science, COCHRANE, CINAHL and Academic Search Premier, Food Science Source and Food Science and Technology Abstracts, Google Scholar and the CAPES Theses & Dissertations Catalog, published in all languages and with no time limit. The selection was carried out by two independent reviewers and any discrepancies were assessed by a third reviewer. The data was extracted using a collection tool developed by the authors after a pilot test. The data will be presented in accordance with the objectives and research questions. Registration of the review in the Open Science Framework-OSF.IO/Y2U6V.
References
American Cancer Society. (2017). What Is Colorectal Cancer? Cancer.org; American Cancer Society. https://www.cancer.org/cancer/colon-rectal-cancer/about/what-is-colorectal-cancer.html
Appunni, S., Rubens, M., Ramamoorthy, V., Tonse, R., Saxena, A., McGranaghan, P., Kaiser, A., & Kotecha, R. (2021). Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer. Frontiers in Nutrition, 8. https://doi.org/10.3389/fnut.2021.718389
Aromataris, E., & Munn, Z. (2020). JBI Manual for Evidence Synthesis (E. Aromataris & Z. Munn, Eds.). JBI. https://doi.org/10.46658/jbimes-20-01
Bodai, B. I., & Nakata, T. E. (2020). Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship. The Permanente Journal, 24. https://doi.org/10.7812/TPP/19.129
Câncer – OPAS/OMS. Organização Pan-Americana da Saúde. (2020, october). www.paho.org. https://www.paho.org/pt/topicos/cancer.
Cordeiro, L., & Baldini Soares, C. (2020). Revisão de escopo: potencialidades para a síntese de metodologias utilizadas em pesquisa primária qualitativa. BIS. Boletim Do Instituto de Saúde, 20(2), 37–43. https://doi.org/10.52753/bis.2019.v20.34471
Detecção Precoce do Câncer MINISTÉRIO DA SAÚDE Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) Ministério de Saúde Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). (n.d.). https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/deteccao-precoce-do-cancer.pdf
Estatísticas de câncer. (2018). INCA - Instituto Nacional de Câncer. https://www.inca.gov.br/numeros-de-cancer
Ferraz, L., Pereira, R. P. G., & Pereira, A. M. R. C. (2019). Tradução do Conhecimento e os desafios contemporâneos na área da saúde: uma revisão de escopo. Saúde Em Debate, 43(spe2), 200–216. https://doi.org/10.1590/0103-11042019s215
Galan-Ros, J., Ramos-Arenas, V., & Conesa-Zamora, P. (2020). Predictive values of colon microbiota in the treatment response to colorectal cancer. Pharmacogenomics, 21(14), 1045–1059. https://doi.org/10.2217/pgs-2020-0044
Loke, Y. L., Chew, M. T., Ngeow, Y. F., Lim, W. W. D., & Peh, S. C. (2020). Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.603086
Ministério da Saúde Instituto Nacional de Câncer José Alencar Gomes da Silva Ministério da Saúde Instituto Nacional de Câncer. (2022). https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf
Nacional De Câncer, I., & Gomes Da Silva, J. (2018). Ministério da saúde. https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/livro-abc-4-edicao.pdf
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., & McGuinness, L. A. (2021). PRISMA 2020 Explanation and elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews. BMJ, 372(160). NCBI. https://doi.org/10.1136/bmj.n160
Peixoto, N. M. dos S. M., Peixoto, T. A. dos S. M., Pinto, C. A. S., & Santos, C. S. V. de B. (2021). Nursing intervention focusing on health promotion behaviors in adult cancer patients: a scoping review. Revista Da Escola de Enfermagem Da USP, 55. https://doi.org/10.1590/s1980-220x2019039403673
Rastreamento Ministério da Saúde. (n.d.). https://bvsms.saude.gov.br/bvs/publicacoes/caderno_atencao_primaria_29_rastreamento.pdf
Silva, A. G., Prates, E. J. S., & Malta, D. C. (2021). Avaliação de programas comunitários de atividade física no Brasil: uma revisão de escopo. Cadernos de Saúde Pública, 37(5). https://doi.org/10.1590/0102-311x00277820
Souza, C. S. C. de, Souza, R. C., Evangelista, J. N., & Ferreira, J. C. S. (2021). A importância da microbiota intestinal e seus efeitos na obesidade. Research, Society and Development, 10(6), e52110616086. https://doi.org/10.33448/rsd-v10i6.16086
Taghinezhad‐S, S., Mohseni, A. H., & Fu, X. (2021). Intervention on gut microbiota may change the strategy for management of colorectal cancer. Journal of Gastroenterology and Hepatology, 36(6), 1508–1517. https://doi.org/10.1111/jgh.15369
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., & Lewin, S. (2018). PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/m18-0850
Villéger, R., Lopès, A., Carrier, G., Veziant, J., Billard, E., Barnich, N., Gagnière, J., Vazeille, E., & Bonnet, M. (2019). Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment? International Journal of Molecular Sciences, 20(18), 4584. https://doi.org/10.3390/ijms20184584
Weersma, R. K., Zhernakova, A., & Fu, J. (2020). Interaction between drugs and the gut microbiome. Gut, 69(8), 1510–1519. https://doi.org/10.1136/gutjnl-2019-320204
World Health Organization. (2022). Cancer. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cancer
Yang, Q., Liang, Q., Balakrishnan, B., Belobrajdic, D., Feng, Q.-J., & Zhang, W. (2020). Role of Dietary Nutrients in the Modulation of Gut Microbiota: A Narrative Review. Nutrients, 12(2), 381. https://doi.org/10.3390/nu12020381
Yixia, Y., Sripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2021). The alterations of microbiota and pathological conditions in the gut of patients with colorectal cancer undergoing chemotherapy. Anaerobe, 102361. https://doi.org/10.1016/j.anaerobe.2021.102361
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jéssica Rosa Thiesen Cunha; Thaís Ortiz Hammes; Eliana Rosa da Fonseca; Elissandra Maria Faiz; Elizete Maria de Souza Bueno; Isabel Cristina Echer
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
